SCHEMBL25848186

SCHEMBL25848186

C=CC(=O)OCC(C)(C)COc1ccc2cc(-c3ccc(CCCCC)cc3OC(F)(F)F)c(=O)oc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.39
KDM4E B2RXH2 6/20 0.37
HPGD P15428 5/20 0.37
NPC1 O15118 7/20 0.37
RAB9A P51151 7/20 0.37
SMN1; SMN2 Q16637 4/20 0.37
ALDH1A1 P00352 4/20 0.37
MAOB P27338 3/20 0.37
GLA P06280 3/20 0.37
GAA P10253 3/20 0.37
MAPT P10636 2/20 0.37
MAOA P21397 1/20 0.37
PKM P14618 1/20 0.37
MAPK1 P28482 1/20 0.37
ATM Q13315 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
PTPN7 P35236 1/20 0.35
STS P08842 1/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22624941 0.93 THRB (0.38) THRBKDM4EHPGDNPC1RAB9A
SCHEMBL25848238 0.93 THRB (0.38) THRBKDM4EHPGDNPC1RAB9A
SCHEMBL22625085 0.92 THRB (0.39) THRBKDM4EHPGDNPC1RAB9A
SCHEMBL25848189 0.92 THRB (0.41) THRBKDM4EHPGDNPC1RAB9A
SCHEMBL22625141 0.92 THRB (0.37) THRBKDM4EHPGDNPC1RAB9A
SCHEMBL22625071 0.90 THRB (0.37) THRBKDM4EHPGDNPC1RAB9A
SCHEMBL25848187 0.90 MAOB (0.37) KDM4EHPGDNPC1RAB9ASMN1; SMN2
SCHEMBL29745824 0.90 MAOB (0.45) THRBKDM4EHPGDNPC1RAB9A
SCHEMBL21065595 0.90 MAOB (0.45) THRBKDM4EHPGDNPC1RAB9A
SCHEMBL25848185 0.89 THRB (0.42) THRBKDM4EHPGDNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11702396-B2 Hydrophobic compounds for optically active devices Johnson & Johnson Surgical Vision, Inc. (US) 2023-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11702396-B2 Hydrophobic compounds for optically active devices UACA, CRYZ, TRPA1 THRB 3289/4885KDM4E 4579/4885HPGD 189/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.